New pain drug may cut post-surgery nausea in women
NCT ID NCT07026162
First seen Jun 13, 2026 · Last updated Jun 13, 2026
Summary
This study tested whether a newer pain medicine, oliceridine, causes less nausea and vomiting than the standard drug sufentanil in women having gynecologic laparoscopic surgery. 96 women aged 18-65 received one of the two medicines during and after surgery. Researchers tracked nausea, vomiting, and side effects for 48 hours to see if oliceridine offers a smoother recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAPAROSCOPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Xiangya Hospital of Central South University
Changsha, Hunan, 410011, China
Conditions
Explore the condition pages connected to this study.